Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of HX008 in Subjects With BCG-Unresponsive Non-muscle Invasive Bladder Cancer

NCT04738630 is registered in ClinicalTrials.gov with Taizhou Hanzhong biomedical co. LTD as lead sponsor.

NCT NCT04738630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-arm, Open-lable, Multicenter, Phase II Clinical Study of HX008 in Subjects With BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Lead sponsor
Taizhou Hanzhong biomedical co. LTD
Phase
Phase 2
Overall status
Unknown status
Start date
September 25, 2020
Completion date
December 1, 2023
Enrollment
110 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer